Emmaus Life Sciences (EMMA) Cash from Operations (2010 - 2026)
Emmaus Life Sciences (EMMA) posted Cash from Operations of $1.69 million for Q2 2026, compared with -$2.91 million a year earlier.
Powered by 
Analysis
Emmaus Life Sciences (EMMA) Cash from Operations (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cash from Operations at Emmaus Life Sciences was $3.97 million; for FY2025, it came in at -$11,000.
- In prior years, Emmaus Life Sciences' Cash from Operations was -$2.29 million in FY2024, -$1.5 million in FY2023, -$5.07 million in FY2022 and -$1.25 million in FY2021.
- Quarterly Cash from Operations has run from a low of -$4.73 million in Q1 2022 to a high of $2.21 million in Q4 2025 over five years.
- On a year-over-year basis, Cash from Operations increased in four of the last five quarters, with growth averaging 181.6%.
- The strongest year-over-year quarter for Cash from Operations in the past five years was Q4 2025, with growth of 544.0%; the weakest was Q4 2024, with a decline of 66.9%.
- According to Business Quant data, Cash from Operations for the three prior quarters was -$344,000 (Q1 2026), $2.21 million (Q4 2025) and $409,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 10.69 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 7.72 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 3.44 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 5.37 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 5.88 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 2.87 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 4.00 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.57 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 835.00 Mn |
| 10 | Emmaus Life Sciences | 4.21 Mn | -2.09 Mn | 5.97 Mn | 1.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.69 Mn |
| Mar 31, 2026 | -344,000.00 |
| Dec 31, 2025 | 2.21 Mn |
| Sep 30, 2025 | 409,000.00 |
| Jun 30, 2025 | -2.91 Mn |
| Mar 31, 2025 | 279,000.00 |
| Dec 31, 2024 | 343,000.00 |
| Sep 30, 2024 | 148,000.00 |
| Jun 30, 2024 | -2.92 Mn |
| Mar 31, 2024 | 140,000.00 |
| Dec 31, 2023 | 1.04 Mn |
| Sep 30, 2023 | 58,000.00 |
| Jun 30, 2023 | -1.31 Mn |
| Mar 31, 2023 | -1.29 Mn |
| Dec 31, 2022 | 1.68 Mn |
| Sep 30, 2022 | -954,000.00 |
| Jun 30, 2022 | -1.06 Mn |
| Mar 31, 2022 | -4.73 Mn |
| Dec 31, 2021 | 865,000.00 |
| Sep 30, 2021 | 1.64 Mn |
API Access
Emmaus Life Sciences Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=EMMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "EMMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=EMMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();